Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,231,000 | 18,577,000 | 38,474,000 | 24,105,000 | 19,980,000 |
| Marketable Securities | 331,000 | 303,000 | 307,000 | 417,000 | 317,000 |
| Receivables | 17,611,000 | 17,846,000 | 16,020,000 | 14,842,000 | 16,174,000 |
| Inventories | 14,146,000 | 13,412,000 | 12,659,000 | 12,444,000 | 12,603,000 |
| TOTAL | $54,611,000 | $54,498,000 | $71,551,000 | $55,893,000 | $53,249,000 |
| Non-Current Assets | |||||
| PPE Net | 22,338,000 | 21,949,000 | 20,871,000 | 20,518,000 | 20,479,000 |
| Intangibles | 96,785,000 | 97,952,000 | 81,223,000 | 81,818,000 | 84,289,000 |
| Other Non-Current Assets | 19,082,000 | 18,990,000 | 20,026,000 | 21,875,000 | 20,270,000 |
| TOTAL | $138,205,000 | $138,891,000 | $122,120,000 | $124,211,000 | $125,038,000 |
| Total Assets | $192,816,000 | $193,389,000 | $193,671,000 | $180,104,000 | $178,287,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,625,000 | 9,464,000 | 9,545,000 | 10,311,000 | 8,954,000 |
| Accrued Expenses | 32,929,000 | 31,525,000 | 29,244,000 | 30,255,000 | 33,509,000 |
| TOTAL | $50,869,000 | $54,180,000 | $56,903,000 | $50,321,000 | $51,759,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 39,408,000 | 39,235,000 | 38,355,000 | 30,651,000 | 31,289,000 |
| Other Non-Current Liabilities | 17,274,000 | 17,702,000 | 17,876,000 | 25,194,000 | 22,129,000 |
| TOTAL | $62,670,000 | $60,736,000 | $58,659,000 | $58,293,000 | $56,370,000 |
| Total Liabilities | $113,539,000 | $114,916,000 | $115,562,000 | $108,614,000 | $108,129,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,409,295 | 2,408,339 | 2,406,073 | 2,407,617 | 2,407,623 |
| Common Shares | 3,120,000 | 3,120,000 | 3,120,000 | 3,120,000 | 3,120,000 |
| Retained earnings | 167,281,000 | 165,371,000 | 162,635,000 | 155,791,000 | 155,179,000 |
| Other shareholders' equity | -15,237,000 | -14,305,000 | -11,740,000 | -11,741,000 | -12,522,000 |
| TOTAL | $79,277,000 | $78,473,000 | $78,109,000 | $71,490,000 | $70,158,000 |
| Total Liabilities And Equity | $192,816,000 | $193,389,000 | $193,671,000 | $180,104,000 | $178,287,000 |